Clinical Trial: A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of a Preventative Vaccine for Marburg Virus (mRNA-1519) in Healthy Adult Participants

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07919210) titled 'A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of a Preventative Vaccine for Marburg Virus (mRNA-1519) in Healthy Adult Participants' on Oct. 30.

Brief Summary: The main objective of this trial is to evaluate the safety, reactogenicity, and immunogenicity of mRNA-1519

Study Start Date: Nov. 02

Study Type: INTERVENTIONAL

Condition: Marburg Virus Disease (MVD)

Intervention: BIOLOGICAL: mRNA-1519

Sterile liquid for injection

BIOLOGICAL: Placebo

Sterile liquid for injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: ModernaTX, Inc.

Disclaimer: Curated by HT Syndication....